Back

Telomere length is associated with adverse atrial remodeling in patients with atrial fibrillation

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Basic science and arrhythmias (1) Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Michael Gramlich

RWTH University Hospital Aachen, Aachen (Germany)

4 More presentations in this session

Presentation thumbnail
Histological validation of clinical classification models of atrial cardiomyopathy
Doctor J. Winters (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Transmurality of post-myocardial infarction scar and the cycle length of ventricular tachycardia
Doctor M. Freeman (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Etripamil - a multichannel modulator to suppress atrial fibrillation
Mr M. Prueser (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.
Doctor P. Tickle (Manchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science and arrhythmias (1)

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Investigating the relationship between the leukocyte telomere length and the incidence of atrial fibrillation: a study utilizing data from the UK Biobank
thumbnail
Congress Presentation
Mechanisms of atrial-fibrillation-induced ventricular dysfunction and recovery in the human left ventricular myocardium
thumbnail
Congress Presentation
Association of telomeres length with cardiovascular risk factors and arterial stiffness

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources